Future Innovations in Medicine: APL and CurifyLabs Collaborate on 3D Printing Technology
Future of Medicine with 3D Printing
Apotek Produktion & Laboratorier (APL), a leading manufacturer of extemporaneous medicines in Sweden, has formed a strategic partnership with CurifyLabs, a Finnish health tech company. Together, they are pioneering 3D printing technology to innovate medicine administration for children and critically ill patients.
Benefits of 3D Printing in Healthcare
- Personalized dosages: Unlike traditional methods, 3D printing allows for tailored dosage forms.
- Precise dosing: This advancement helps minimize side effects associated with incorrect dosages.
- Environmental sustainability through reduced waste during production.
APL's current manufacturing method yields at least 100 capsules per batch. However, embracing 3D printing enables the creation of specific doses with minimal waste. This approach could promote better work conditions, lowering the risk of repetitive strain injuries and exposure to hazardous substances.
In a statement, APL expressed admiration for CurifyLabs' dedication to tackling the pressing needs of critically ill patients. They believe that 3D printing aligns perfectly with their mission to advance public healthcare initiatives.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.